| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
8e-07 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |